Abstract Background Globally, 14.3% of women of reproductive age use intrauterine
contraception (IUC), but the distribution of IUC users is strikingly nonuniform. In some …

PURPOSE: To discuss common myths and misconceptions about long-acting reversible
contraception (LARC) among patients and health care providers. METHODS: We address …

Few developments have received as much attention or palpable enthusiasm in the
reproductive field in recent decades as long-acting reversible contraception (LARC). Though …

OBJECTIVE: To identify an appropriate dose for a new contraceptive levonorgestrel
intrauterine system (LNG-IUS). DESIGN: Randomized, open-label, three-arm, phase II study …

OBJECTIVE: To evaluate the efficacy and safety of two low-dose levonorgestrel intrauterine
contraceptive systems. METHODS: Nulliparous and parous women aged 18− 35 years with …

OBJECTIVE: To examine predictors of health care providers perceiving intrauterine devices
(IUDs) as unsafe for nulliparous women and of infrequent provision of IUDs to nulliparous …

Objective To provide guidelines for health care providers on the use of contraceptive
methods to prevent pregnancy and on the promotion of healthy sexuality. Outcomes Overall …

The provision of effective contraception is fundamental to the practice of women's health
care. The most effective methods of reversible contraception are the so-called long-acting …

Abstract Objectives Intrauterine contracepives (IUCs) are highly effective and safe for use in
all women, including those who are nulliparous. However, many myths and barriers prevent …

Adolescents and young women were historically excluded from receiving long-acting
reversible contraceptives (LARC) such as intrauterine devices (IUDs) after widespread …